This HTML5 document contains 18 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
dbpedia-owlhttp://dbpedia.org/ontology/
n5http://www.daiichisankyo.com/
foafhttp://xmlns.com/foaf/0.1/
n8http://dbpedia.org/resource/President_(corporate_title)
rdfshttp://www.w3.org/2000/01/rdf-schema#
n6http://dbpedia.org/resource/Chūō,
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
dbpediahttp://dbpedia.org/resource/
Subject Item
dbpedia:Daiichi_Sankyo
rdfs:comment
Daiichi Sankyo Company, Limited (第一三共株式会社, Daiichi Sankyō Kabushiki-kaisha) is a global pharmaceutical company and the second largest pharmaceutical company in Japan. It achieved JPY 1,148.2 billion in revenue in 2013. The company owns the American biotechnology company Plexxikon, the German biotechnology company U3 Pharma and recently sold Ranbaxy Laboratories in India. Daiichi Sankyo Co., Ltd.
foaf:name
Daiichi Sankyo Company, Limited
foaf:homepage
n5:
dbpedia-owl:foundationPlace
dbpedia:Tokyo dbpedia:Japan
dbpedia-owl:foundingYear
2005-01-01Z
dbpedia-owl:industry
dbpedia:Pharmaceutical_industry
dbpedia-owl:keyPerson
dbpedia:Chief_executive_officer dbpedia:Chairman n8:
dbpedia-owl:location
n6:_Tokyo dbpedia:Tokyo dbpedia:Japan dbpedia:Nihonbashi
dbpedia-owl:numberOfEmployees
32229
dbpedia-owl:revenue
1.2006E10 9.97852E11
dbpedia-owl:type
dbpedia:Public_company